Language: 简体中文 English

您的位置: 首页 > 会议动态 > 正文

Pancras C.W. Hogendoorn

Leiden University Medical Center

更新时间:2019/7/18 15:03:42

Pancras C.W. Hogendoorn

Pancras C.W. Hogendoorn is a professor of pathology, a memberof the Board of Directors, and the dean of the Leiden University Medical Center(LUMC). Apart from that he is a guest professor at Oxford University and the Free University of Brussels (FUB). He is also chairman of the Netherlands Committee for Bone Tumours, a member of the Supervisory Board of the care organisation Pieter van Foreest, the National Museum Boerhaave, and the Royal Academy of Arts. Pancras C.W. Hogendoorn absolved Medical School and his doctoral research at Leiden University. The title of his doctoral thesis(1990) reads ‘Immunopathogenetic mechanisms in experimental glomerulonephritis’. Subsequently Prof. Hogendoorn further specialized inoncologic pathology at the Netherlands Cancer Institute (NKI) in Amsterdam andthe Memorial Sloan Kettering Cancer Center in New York. In March 1999 he was appointed Professor in Pathology of the Leiden University Medical Center. The title of his inaugural lecture was ‘Form Follows Function’. For more than 25years, Prof. Hogendoorn has carried out research into molecular pathogenesis and diagnostics of bone and soft-tissue tumours. He has over 400 scientific publications and various influential reviews and 23 chapters of books to his name. Prof. Hogendoorn has held a number of national and international offices at scientific organizations. Currently he is chairman of the Netherlands Committee for Bone Tumours, a member of the knowledge coalition for the Dutch National Research Agenda, chairman of the Bone and Soft Tissue working group European Society of Pathology, chairman of Education and Training (O&O) atthe Netherlands Federation of University Medical Centres (NFU), and chairman of the League of European Research Universities (LERU) Policy Group in Biomedicine. In the past he was, among other things, chairman of the sub-committee of Pathology and Biology of the EORTC Soft tissue and Bone Sarcoma Group, the European Osteosarcoma Intergroup, the Euro Ewing consortium, chairman of Eurolife, and a board member of the Connective Tissue Oncology Society and the European Musculoskeletal Oncology Society. Prof. Hogendoorn was a member of the advisory board of the prestigious Journal of Pathology. He held the same post for Diagnostic Histopathology and Hereditary Cancer in Clinical Practice. Prof. Hogendoorn is still an active member of the working group of bone and soft-tissue tumours of the European Society for Pathology and the United States Academy of Pathology. Because of his research and diagnostic work in the field of bone and soft-tissue tumours, the World Health Organisation(WHO) asked him in 2002 to join the working group for the classification of these tumours. As such he was a co-author of the WHO classification for bone and soft-tissue tumours and was in 2013 appointed editor of the most recent edition.